COVID Drug Bazaar: Who's behind the black marketing of Remdesivir? : News Reel: Business Today
Business Today
Loading...
 

COVID Drug Bazaar: Who's behind the black marketing of Remdesivir?

Rajeev Dubey | July 17, 2020

Sharks in the pharma supply chains are stockpiling and black-marketing a key life-saving drug for Covid-19, an India Today investigation has found. Remdesivir, produced by America's Gilead Sciences, is touted as the best hope for critically-ill coronavirus patients for its ability to shorten recovery times in clinical trials. India Today's undercover investigation has found that those who need remdesivir to keep them alive may not be able to afford it because of its excessive pricing on the black market. But, who's at fault? Rajeev Dubey, Editor, Business Today explains.

Also Read: Coronavirus vaccine update: COVAXIN human trials start at PGI Rohtak



    More from this section